BioAtla (BCAB) Market Capitalization (2020 - 2026)

BioAtla (BCAB) has reported Market Capitalization for 7 consecutive years, with $6.9 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Market Capitalization fell 99.41% year-over-year to $6.9 million; the trailing twelve-month figure through Jun 2026 stood at $6.9 million (down 99.41% YoY), and the FY2025 full-year result was $1.8 billion, up 4.89% from the prior year.
• Market Capitalization retreated to $6.9 million in Q2 2026 per BCAB's latest filing, from $13.4 million in the prior quarter.
• Across five years, Market Capitalization topped out at $19.1 billion in Q4 2022 and bottomed at $6.9 million in Q2 2026.
• Historically, Market Capitalization has averaged $5.2 billion across 5 years, with a median of $4.2 billion in 2023.
• The sharpest annual moves came in 2023 and 2026: Market Capitalization soared 39.8% in 2023, then plunged 99.41% in 2026.
• Over 5 years, Market Capitalization stood at $19.1 billion in 2022, then tumbled by 69.06% to $5.9 billion in 2023, then plunged by 70.96% to $1.7 billion in 2024, then rose by 4.89% to $1.8 billion in 2025, then sank by 99.62% to $6.9 million in 2026.
• According to Business Quant data, Market Capitalization over the past three periods registered $6.9 million, $13.4 million, and $1.8 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.